Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Penetrating Peptides for Cytosolic mRNA Delivery
Bioconjugate Chemistry · 18.10.2023 · 34 (10) · 1822-1834
DOI: 10.1021/acs.bioconjchem.3c00346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 21.09.2023. Verfasst von Rik Oude Egberink und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical BioSciences, Research Institute for Medical Innovation, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Cell-Penetrating Peptides. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nierstichting, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
The formation of noncovalent complexes by mixing of positively charged polymers with negatively charged oligonucleotides (ONs) is a widely explored concept in nanomedicine to achieve cellular delivery of ONs. Uptake of ON complexes occurs through endocytosis, which then requires release of ON from endosomes. As one type of polymer, cell-penetrating peptides (CPPs) are being used which are peptides of about 8-30 amino acids in length. However, only a few CPPs yield effective cytosolic ON delivery and activity. Several strategies have been devised to increase cellular uptake and enhance endosomal release, among which an increase of osmotic pressure through the so-called proton sponge effect, disruption of membrane integrity through membrane activity, and disulfide-mediated polymerization. Here, we address the relevance of these concepts for mRNA delivery by incorporating structural features into the human lactoferrin-derived CPP, which shows uptake but not delivery. The incorporation of histidines was explored to address osmotic pressure and structural motifs of the delivery-active CPP PepFect14 (PF14) to address membrane disturbance, and finally, the impact of polymerization was explored. Whereas oligomerization increased the stability of polyplexes against heparin-induced decomplexation, neither this approach nor the incorporation of histidine residues to promote a proton-sponge effect yielded activity. Also, the replacement of arginine residues with lysine or ornithine residues, as in PF14, was without effect, even though all polyplexes showed cellular uptake. Ultimately, sufficient activity could only be achieved by transferring amphipathic sequence motifs from PF14 into the hLF context with some benefit of oligomerization demonstrating overarching principles of delivery for CPPs, lipid nanoparticles, and other types of delivery polymers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical BioSciences, Research Institute for Medical Innovation, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
- Department of Medical Biochemistry, College of Medicine and Medical Sciences, Arabian Gulf University, Manama 329, Bahrain.
ORCID-Profile: Roland Brock
Förderung
- Nierstichting
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Egberink, R. O., van Asbeck, A. H., Boswinkel, M., Muradjan, G., Dieker, J., & Brock, R. (2023). Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Penetrating Peptides for Cytosolic mRNA Delivery. Bioconjugate Chemistry, 34(10), 1822-1834. https://doi.org/10.1021/acs.bioconjchem.3c00346
Vancouver
Egberink RO, van Asbeck AH, Boswinkel M, Muradjan G, Dieker J, Brock R. Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Penetrating Peptides for Cytosolic mRNA Delivery. Bioconjugate Chemistry. 2023;34(10):1822-1834. doi:10.1021/acs.bioconjchem.3c00346
BibTeX
@article{Egberink2023,
author = {Egberink, Rik Oude and van Asbeck, Alexander H and Boswinkel, Milou and Muradjan, Grigor and Dieker, Jürgen and Brock, Roland},
title = {Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Penetrating Peptides for Cytosolic mRNA Delivery},
journal = {Bioconjugate Chemistry},
year = {2023},
volume = {34},
number = {10},
pages = {1822--1834},
doi = {10.1021/acs.bioconjchem.3c00346}
}
EUVIMED